EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   2.4.1.47 | more |
- |
Homo sapiens |
? |
- |
? |
| 2.4.1.47 | more |
- |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.47 | more |
not: galactose, galactose-1-phosphat, ADP-galactose |
Gallus gallus |
? |
- |
? |
| 2.4.1.47 | more |
not: glucosylceramide, lactosylceramide, asialo GM2ganglioside |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.47 | more |
not: ceramide containing nonhydroxy fatty acids |
Mus musculus |
? |
- |
? |
| 2.4.1.47 | more |
not: ceramide containing nonhydroxy fatty acids |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.47 | more |
final step of galactosylceramide synthesis, which plays a role in myelin formation, signal transduction and oligodendrocyte development |
Homo sapiens |
? |
- |
? |
| 2.4.1.47 | more |
key enzyme in the biosynthesis of cerebrosides and sulfatides, cell-specific and highly time-regulated expression of the CGT gene is thought to play an important role in oligodendrocyte and Schwann cell differentiation |
Mus musculus |
? |
- |
? |
| 2.4.1.47 | more |
oligodendrocyte-specific enzyme is involved in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides, time-regulated CGT expression with a peak around postnatal days 15-25 |
Rattus norvegicus |
? |
- |
? |
| 2.4.1.47 | more |
last step in biosynthesis of cerebrosides |
Rattus norvegicus |
? |
- |
? |
